FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998755334> ?p ?o ?g. }

• W2998755334 endingPage "103" @default.
• W2998755334 startingPage "98" @default.
• W2998755334 abstract "Objective To explore the relationship between hepatic cytochrome P450 2C19 ( CYP2C19 ) gene polymorphisms and the effectiveness and safety of thalidomide in the treatment of patients with immune‐related bowel disease (IRBD). Methods CYP2C19 variants in 79 patients treated with thalidomide were analyzed using a polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP). The clinical response and adverse events of the thalidomide treatment were recorded. The potential influences of the CYP2C19 genotype polymorphisms on the clinical efficacy and adverse events of thalidomide were then investigated. Results Altogether 79 patients with IRBD (70 with Crohn's disease, three with ulcerative colitis and six with Behcet's disease) receiving thalidomide therapy were recruited from January 2013 to February 2015 in a tertiary IBD center in China. Overall, 21.5% (17/79) of these patients had CYP2C19 poor metabolizers genotype (PM). The overall response rate and the incidence of adverse events of CYP2C19 extensive metabolizers genotype were not significantly different from that of the PM when IRBD patients were treated with thalidomide ( P = 0.517 and 0.816, respectively). Conclusion CYP2C19 polymorphisms do not seem to be associated with efficacy of thalidomide and the incidence of adverse events in treating IRBD." @default.
• W2998755334 created "2020-01-23" @default.
• W2998755334 creator A5002494268 @default.
• W2998755334 creator A5003726335 @default.
• W2998755334 creator A5012122902 @default.
• W2998755334 creator A5039650364 @default.
• W2998755334 creator A5040582111 @default.
• W2998755334 creator A5051989902 @default.
• W2998755334 creator A5059225203 @default.
• W2998755334 creator A5065442049 @default.
• W2998755334 creator A5072668725 @default.
• W2998755334 date "2020-02-01" @default.
• W2998755334 modified "2023-10-16" @default.
• W2998755334 title "<i>CYP2C19</i> polymorphism has no correlation with the efficacy and safety of thalidomide in the treatment of immune‐related bowel disease" @default.
• W2998755334 cites W1536291316 @default.
• W2998755334 cites W2008552783 @default.
• W2998755334 cites W2011405088 @default.
• W2998755334 cites W2014014913 @default.
• W2998755334 cites W2086684499 @default.
• W2998755334 cites W2095294682 @default.
• W2998755334 cites W2101606846 @default.
• W2998755334 cites W2118051691 @default.
• W2998755334 cites W2121098498 @default.
• W2998755334 cites W2122207878 @default.
• W2998755334 cites W2131343445 @default.
• W2998755334 cites W2132788452 @default.
• W2998755334 cites W2147773457 @default.
• W2998755334 cites W2179756474 @default.
• W2998755334 cites W225484341 @default.
• W2998755334 cites W2319412069 @default.
• W2998755334 cites W2398008550 @default.
• W2998755334 cites W2469581016 @default.
• W2998755334 cites W2508424839 @default.
• W2998755334 cites W2602296492 @default.
• W2998755334 cites W315812671 @default.
• W2998755334 cites W4211136726 @default.
• W2998755334 doi "https://doi.org/10.1111/1751-2980.12842" @default.
• W2998755334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31916702" @default.
• W2998755334 hasPublicationYear "2020" @default.
• W2998755334 type Work @default.
• W2998755334 sameAs 2998755334 @default.
• W2998755334 citedByCount "2" @default.
• W2998755334 countsByYear W29987553342021 @default.
• W2998755334 countsByYear W29987553342022 @default.
• W2998755334 crossrefType "journal-article" @default.
• W2998755334 hasAuthorship W2998755334A5002494268 @default.
• W2998755334 hasAuthorship W2998755334A5003726335 @default.
• W2998755334 hasAuthorship W2998755334A5012122902 @default.
• W2998755334 hasAuthorship W2998755334A5039650364 @default.
• W2998755334 hasAuthorship W2998755334A5040582111 @default.
• W2998755334 hasAuthorship W2998755334A5051989902 @default.
• W2998755334 hasAuthorship W2998755334A5059225203 @default.
• W2998755334 hasAuthorship W2998755334A5065442049 @default.
• W2998755334 hasAuthorship W2998755334A5072668725 @default.
• W2998755334 hasConcept C104317684 @default.
• W2998755334 hasConcept C120665830 @default.
• W2998755334 hasConcept C121332964 @default.
• W2998755334 hasConcept C126322002 @default.
• W2998755334 hasConcept C135763542 @default.
• W2998755334 hasConcept C140840227 @default.
• W2998755334 hasConcept C197934379 @default.
• W2998755334 hasConcept C2776364478 @default.
• W2998755334 hasConcept C2777498785 @default.
• W2998755334 hasConcept C2779134260 @default.
• W2998755334 hasConcept C2779609412 @default.
• W2998755334 hasConcept C526171541 @default.
• W2998755334 hasConcept C54355233 @default.
• W2998755334 hasConcept C61511704 @default.
• W2998755334 hasConcept C62231903 @default.
• W2998755334 hasConcept C71924100 @default.
• W2998755334 hasConcept C76252995 @default.
• W2998755334 hasConcept C86803240 @default.
• W2998755334 hasConcept C90924648 @default.
• W2998755334 hasConceptScore W2998755334C104317684 @default.
• W2998755334 hasConceptScore W2998755334C120665830 @default.
• W2998755334 hasConceptScore W2998755334C121332964 @default.
• W2998755334 hasConceptScore W2998755334C126322002 @default.
• W2998755334 hasConceptScore W2998755334C135763542 @default.
• W2998755334 hasConceptScore W2998755334C140840227 @default.
• W2998755334 hasConceptScore W2998755334C197934379 @default.
• W2998755334 hasConceptScore W2998755334C2776364478 @default.
• W2998755334 hasConceptScore W2998755334C2777498785 @default.
• W2998755334 hasConceptScore W2998755334C2779134260 @default.
• W2998755334 hasConceptScore W2998755334C2779609412 @default.
• W2998755334 hasConceptScore W2998755334C526171541 @default.
• W2998755334 hasConceptScore W2998755334C54355233 @default.
• W2998755334 hasConceptScore W2998755334C61511704 @default.
• W2998755334 hasConceptScore W2998755334C62231903 @default.
• W2998755334 hasConceptScore W2998755334C71924100 @default.
• W2998755334 hasConceptScore W2998755334C76252995 @default.
• W2998755334 hasConceptScore W2998755334C86803240 @default.
• W2998755334 hasConceptScore W2998755334C90924648 @default.
• W2998755334 hasFunder F4320321001 @default.
• W2998755334 hasIssue "2" @default.
• W2998755334 hasLocation W29987553341 @default.
• W2998755334 hasLocation W29987553342 @default.
• W2998755334 hasOpenAccess W2998755334 @default.
• W2998755334 hasPrimaryLocation W29987553341 @default.

• next